The U.S. Food and Drug Administration expanded approval for Johnson & Johnsons nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the com… [read more]
FDA approves standalone use of J&J’s ketamine-derived depression treatment – CNN
- Post author:
- Post published:January 23, 2025
- Post category:Business News
- Post comments:0 Comments
You Might Also Like

Jim Cramer gives his take on Federal Reserve Chairman Jerome Powell’s speech on Wednesday – CNBC Television

Americans are worse off now than when Biden took office: Hassett – Fox Business
